Edition:
International

Rebecca Spalding

U.S. COVID-19 vaccine rollout analysis hampered by technology, state data reporting

Apr 01 2021

When a dose of a COVID-19 vaccine leaves a U.S. manufacturing plant, its path can be traced all the way to the hospital or clinic representative signing for the shipment at its destination. What happens next is not always clear.

Canadian Pacific to buy Kansas City Southern in $25 billion railway bet on trade

Mar 21 2021

Canadian Pacific Railway Ltd agreed on Sunday to acquire Kansas City Southern in a $25 billion cash-and-stock deal to create the first railway spanning the United States, Mexico and Canada, standing to benefit from a pick-up in trade.

Telehealth company Ro to offer in-home COVID-19 vaccinations in New York state

Mar 03 2021

Telehealth company Ro said on Wednesday it was partnering with New York state's department of health to vaccinate people who can't leave their homes against COVID-19.

White House to roll out Johnson & Johnson vaccine doses next week, pending authorization

Feb 24 2021

The United States expects to roll out three to four million doses of Johnson & Johnson's COVID-19 vaccine next week, pending authorization from the Food and Drug Administration, White House COVID-19 response coordinator Jeff Zients said on Wednesday. | Video

U.S. storms delay COVID-19 vaccines in all 50 states: White House

Feb 19 2021

The United States has a backlog of six million COVID-19 vaccine doses due to winter storms and power outages weather, White House officials said at a media briefing on Friday, adding that the federal government expects to catch up with vaccine distribution by next week.

Human tissue developer Humacyte agrees to SPAC merger to go public

Feb 17 2021

NEW YORK, Feb 17 Humacyte Inc, a developer of universally implantable bioengineered human tissues and organs, said on Wednesday it has agreed to a deal to go public through a merger with blank-check acquisition company Alpha Healthcare Acquisition Corp.

GSK, Vir Biotech to expand COVID-19 research partnership for other diseases

Feb 17 2021

GlaxoSmithKline and Vir Biotechnology Inc will expand an existing partnership developing antibody therapies for COVID-19 to other diseases, the companies said on Wednesday.

GSK, Vir Biotech to expand COVID-19 research partnership for other diseases

Feb 17 2021

Feb 17 British drugmaker GlaxoSmithKline Plc and Vir Biotechnology Inc will expand their existing partnership developing antibody therapies for COVID-19 to research therapies for other diseases, the companies said on Wednesday.

Human tissue developer Humacyte nears SPAC deal to go public - sources

Feb 16 2021

NEW YORK Humacyte Inc, a developer of universally implantable bioengineered human tissues and organs, has agreed a deal to go public through a merger with blank-check acquisition company Alpha Healthcare Acquisition Corp, according to people familiar with the matter.

World News